themedicinescompany.com stats and valuation
Website Information
- Title
- Novartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigational cholesterol-lowering therapy inclisiran | Novartis
- robots
- follow, index
- rating
- general
- referrer
- no-referrer
- twitter:site
- @novartis
- twitter:site:id
- 17226612
- mobileoptimized
- width
- handheldfriendly
- true
- viewport
- width=device-width,initial-scale=1,user-scalable=no,maximum-scale=1
- Important Html Tags
- H1 0
- H2 0
- H3 0
- H4 0
- STRONG 0
- A 75
- IMG 1
- Page Size
- 64Kb
- Code to Text Ratio
- 2.52% (Text size 1.61Kb and Code size 62.39Kb)
- Http Header
HTTP/1.1 301 Moved Permanently Date: Sat, 12 Dec 2020 07:17:32 GMT Content-Type: text/html; charset=iso-8859-1 Transfer-Encoding: chunked Connection: keep-alive Set-Cookie: __cfduid=de1cc9f5999e47ae49541706f4229160c1607757451; expires=Mon, 11-Jan-21 07:17:31 GMT; path=/; domain=.themedicinescompany.com; HttpOnly; SameSite=Lax X-Content-Type-Options: nosniff Location: https://www.themedicinescompany.com/ Cache-Control: max-age=1209600 Expires: Fri, 25 Dec 2020 06:09:22 GMT X-Request-ID: v-69f19aec-3b77-11eb-9f4e-ff4eb6caed61 Age: 90489 Via: varnish X-Cache: HIT X-Cache-Hits: 57 CF-Cache-Status: DYNAMIC cf-request-id: 06f768eabb00000f1afe35e000000001 Server: cloudflare CF-RAY: 6005aa8acfb00f1a-DFW HTTP/1.1 307 Temporary Redirect Date: Sat, 12 Dec 2020 07:17:32 GMT Content-Type: text/html; charset=UTF-8 Transfer-Encoding: chunked Connection: keep-alive Set-Cookie: __cfduid=d071f9545445eb7bbe5758f77029a778a1607757452; expires=Mon, 11-Jan-21 07:17:32 GMT; path=/; domain=.themedicinescompany.com; HttpOnly; SameSite=Lax X-Redirect-ID: 61 Cache-Control: public, max-age=300 X-UA-Compatible: IE=edge Content-language: en X-Content-Type-Options: nosniff X-Frame-Options: SAMEORIGIN Expires: Sat, 12 Dec 2020 07:22:32 GMT Vary: X-Generator: Drupal 8 (https://www.drupal.org) Strict-Transport-Security: max-age=31536000; includeSubDomains; preload X-Drupal-Cache: HIT Location: https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-medicines-company-adding-potentially-first-class-investigational-cholesterol-lowering-therapy-inclisiran X-Request-ID: v-19c9809c-3c4a-11eb-962d-b770628a756e X-AH-Environment: prod Via: varnish X-Cache: MISS CF-Cache-Status: MISS cf-request-id: 06f768eb7c0000ec66061a7000000001 Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" Server: cloudflare CF-RAY: 6005aa8bff30ec66-DFW HTTP/1.1 200 OK Date: Sat, 12 Dec 2020 07:17:33 GMT Content-Type: text/html; charset=utf-8 Transfer-Encoding: chunked Connection: keep-alive Set-Cookie: __cfduid=db739462425a8899a037ff1fed14043091607757452; expires=Mon, 11-Jan-21 07:17:32 GMT; path=/; domain=.novartis.com; HttpOnly; SameSite=Lax; Secure X-Drupal-Cache: MISS X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN Strict-Transport-Security: max-age=31536000; includeSubDomains Content-Language: en X-UA-Compatible: IE=edge,chrome=1 Link: <https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-medicines-company-adding-potentially-first-class-investigational-cholesterol-lowering-therapy-inclisiran>; rel="canonical",<https://www.novartis.com/node/143991>; rel="shortlink" Cache-Control: public, max-age=60 Last-Modified: Sat, 12 Dec 2020 07:05:11 GMT Expires: Sun, 19 Nov 1978 05:00:00 GMT Vary: Cookie,Accept-Encoding X-Request-ID: v-60405ebc-3c48-11eb-9d68-b30c507167cf X-AH-Environment: prod Via: varnish X-Cache: HIT X-Cache-Hits: 1 CF-Cache-Status: REVALIDATED cf-request-id: 06f768ece90000ec8eed1db000000001 Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" Server: cloudflare CF-RAY: 6005aa8e4ae1ec8e-DFW
